Frontier IP Group
Dr David Holbrook is a leading healthcare investment technology professional with 30 years’ experience in the life sciences sectors. He has sat on more than 20 boards of directors during his career. He is currently a non-executive director at Oxford BioDynamics plc and a senior adviser to RYSE Asset Management. Trained as a physician, David has also held senior business development roles at Glaxo, Roche and in biotech, and has an MBA from Harvard.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Frontier IP Group
Frontier IP Group plc is an AIM listed UK based specialist asset management group whose focus and purpose is to provide consultancy services to assist universities and research organisations in the commercialisation of intellectual property arising fro...